0001933414-24-000018.txt : 20240523 0001933414-24-000018.hdr.sgml : 20240523 20240523162051 ACCESSION NUMBER: 0001933414-24-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Litzka Olivier CENTRAL INDEX KEY: 0001963940 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41614 FILM NUMBER: 24978569 MAIL ADDRESS: STREET 1: C/O MINERALYS THERAPEUTICS, INC. STREET 2: 150 N. RADNOR CHESTER RD, STE. F200 CITY: RADNOR STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mineralys Therapeutics, Inc. CENTRAL INDEX KEY: 0001933414 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: (888) 378-6240 MAIL ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 4 1 wk-form4_1716495632.xml FORM 4 X0508 4 2024-05-22 0 0001933414 Mineralys Therapeutics, Inc. MLYS 0001963940 Litzka Olivier 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 1 0 0 0 0 Stock Option 12.52 2024-05-22 4 A 0 22000 0 A 2034-05-22 Common Stock 22000 22000 D The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting. /s/ Adam Levy, Attorney-in-fact 2024-05-23